Getting started with a Monitored DataBase MDB
Sunday 23 May 2010We already have got opportunity to detail principles, rationale and running of these new “Monitored” Data Bases MDB… It is great time right now to present upon a practical means three tutorials describing in details the three serial steps which allow for getting a MDB linked to any other existing “agreed” RDV, then for customizing this MDB as to fit the requirements of the pending study, and finally using this MDB to carry out at best the clinical study upon the regulatory commitments about follow-up for enrolled cases.
These three tutorials thus comprise: (1) Settings by the Local Administrator of the “transmitting” RDB allowing for CRFs to get linked with the corresponding MDB by those among all users of this RDB that have been agreed to participate in the study and so to include their cases. The tutorial also describes how these users can “send” their arthroplasty forms to the MDB. (2) The second tutorial is devoted to the set up of the MDB itself by the Local Administrator of this MDB (who generally is different from the “transmitting” RDB Administrator). This set up regards the various parameters of the study, and firstly the agreed users including their rights for getting access to CRFs, choice of follow-up periods to be considered, and used clinical scores, as well as any kind of administrative data allowing the Manager to get in touch at any time with any of the actors participating in the ongoing study. (3) The third tutorial at last, is in fact the most important as it details the practical use of these MDBs while carrying out any study, namely with respect to the three specific MDB sub-tabs devoted to the display of the official protocol, as well as current statistics about inclusions of CRFs and status at the various follow-up periods, and also the directory of all enrolled patients with personal status according to their participation in the study. The monitoring of any clinical study can thus be performed ideally and on real time… Lire le reste de cet article »




